{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:09:03Z","timestamp":1784779743129,"version":"3.55.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["875510"],"award-info":[{"award-number":["875510"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011961","name":"set Foundation for the Funding of Research on Alternative and Complementary Methods for the Restriction on Animal Experiments","doi-asserted-by":"publisher","award":["P-070"],"award-info":[{"award-number":["P-070"]}],"id":[{"id":"10.13039\/501100011961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003495","name":"Hessisches Ministerium f\u00fcr Wissenschaft und Kunst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003495","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001663","name":"Volkswagen Foundation","doi-asserted-by":"publisher","award":["A137334"],"award-info":[{"award-number":["A137334"]}],"id":[{"id":"10.13039\/501100001663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001663","name":"Volkswagen Foundation","doi-asserted-by":"publisher","award":["03ZU2109GA"],"award-info":[{"award-number":["03ZU2109GA"]}],"id":[{"id":"10.13039\/501100001663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004203","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004203","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejpb.2025.114966","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:12:20Z","timestamp":1765843940000},"page":"114966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Development of spray-dried phage-aztreonam microparticles for inhalation therapy of Pseudomonas aeruginosa lung infections"],"prefix":"10.1016","volume":"219","author":[{"given":"Alexandra","family":"H\u00fcbl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Most","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hau\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Planz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9475-699X","authenticated-orcid":false,"given":"Maike","family":"Windbergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114966_b0005","unstructured":"World Health Organization WHO, WHO Bacterial Priority Pathogens List 2024. Bacterial Pathogens of Public Health Importance, to Guide Research, Development, and Strategies to Prevent and Control Antimicrobial Resistance. https:\/\/www.who.int\/publications\/i\/item\/9789240093461, 2024 (accessed 28 August 2025)."},{"key":"10.1016\/j.ejpb.2025.114966_b0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12941-020-00389-5","article-title":"Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review","volume":"19","author":"Chegini","year":"2020","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.ejpb.2025.114966_b0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/CMR.17.1.57-71.2004","article-title":"Infection Control in Cystic Fibrosis","volume":"17","author":"Saiman","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejpb.2025.114966_b0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ppul.1950120306","article-title":"Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis","volume":"12","author":"Henry","year":"1992","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ejpb.2025.114966_b0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/CMR.00068-09","article-title":"The Changing Microbial Epidemiology in Cystic Fibrosis","volume":"23","author":"LiPuma","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejpb.2025.114966_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2023.1209534","article-title":"Design of respirable sprayed microparticles of encapsulated bacteriophages","volume":"3","author":"Baldelli","year":"2023","journal-title":"Front. Drug Deliv."},{"key":"10.1016\/j.ejpb.2025.114966_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.758392","article-title":"Prospects of Inhaled Phage Therapy for Combatting Pulmonary Infections","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejpb.2025.114966_b0040","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","article-title":"Pulmonary Clinical Practice Guidelines Committee, Cystic Fibrosis Pulmonary Guidelines. Chronic Medications for Maintenance of Lung Health","volume":"187","author":"Mogayzel","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejpb.2025.114966_b0045","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1378\/chest.08-1421","article-title":"Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis","volume":"135","author":"Retsch-Bogart","year":"2009","journal-title":"Chest."},{"key":"10.1016\/j.ejpb.2025.114966_b0050","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/ppul.21301","article-title":"An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis","volume":"45","author":"Oermann","year":"2010","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ejpb.2025.114966_b0055","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1093\/jac\/dkr303","article-title":"Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI)","volume":"66","author":"Oermann","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejpb.2025.114966_b0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.addr.2018.08.001","article-title":"Phage therapy for respiratory infections","volume":"133","author":"Chang","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114966_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2017.09.002","article-title":"Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection","volume":"121","author":"Chang","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114966_b0070","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.70021","article-title":"Multifunctional Nanocarriers in Bacteriophage Delivery: A Paradigm Shift in Treating Multidrug-Resistant Infections","volume":"17","author":"Patil","year":"2025","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ejpb.2025.114966_b0075","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/thoraxjnl-2016-209265","article-title":"Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa","volume":"72","author":"Waters","year":"2017","journal-title":"Thorax."},{"key":"10.1016\/j.ejpb.2025.114966_b0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.33073\/pjm-2014-019","article-title":"Bacteriophages as an Alternative Strategy for Fighting Biofilm Development","volume":"63","author":"Parasion","year":"2014","journal-title":"Pol. J. Microbiol."},{"key":"10.1016\/j.ejpb.2025.114966_b0085","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2174\/1389201024666221207114047","article-title":"Phage Therapy as a Protective Tool Against Pathogenic Bacteria: How Far We Are?","volume":"24","author":"Singh","year":"2023","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ejpb.2025.114966_b0090","doi-asserted-by":"crossref","DOI":"10.1111\/1751-7915.70193","article-title":"Phage-Antibiotic Combinations for Pseudomonas: Successes in the Clinic and In Vitro Tenuously Connected","volume":"18","author":"Fatima","year":"2025","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.ejpb.2025.114966_b0095","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3390\/pharmaceutics17081077","article-title":"Latest Advances in Inhalable Dry Powder Bacteriophage Therapy for Pulmonary Infections","volume":"17","author":"Encinas-Basurto","year":"2025","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejpb.2025.114966_b0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fcimb.2019.00022","article-title":"Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy","volume":"9","author":"Tagliaferri","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejpb.2025.114966_b0105","article-title":"Enhanced anti-P. aeruginosa treatment via phage and ciprofloxacin co-loaded particles prepared by electrospraying","volume":"180","author":"Liu","year":"2025","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.ejpb.2025.114966_b0110","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejpb.2020.11.019","article-title":"Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation-A proof-of-principle study in a P. aeruginosa lung infection model","volume":"158","author":"Lin","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114966_b0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/jamp.2021.0045","article-title":"Inhaled Delivery of Anti-Pseudomonal Phages to Tackle Respiratory Infections Caused by Superbugs","volume":"35","author":"Chan","year":"2022","journal-title":"J. Aerosol. Med. Pulm. Drug. Deliv."},{"key":"10.1016\/j.ejpb.2025.114966_b0120","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/eva.12364","article-title":"Long-term effects of single and combined introductions of antibiotics and bacteriophages on populations of Pseudomonas aeruginosa","volume":"9","author":"Torres-Barcel\u00f3","year":"2016","journal-title":"Evol. Appl."},{"key":"10.1016\/j.ejpb.2025.114966_b0125","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.7150\/ijbs.60551","article-title":"A combination therapy of Phages and Antibiotics: Two is better than one","volume":"17","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejpb.2025.114966_b0130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/microorganisms13010100","article-title":"Bacteriophages: A Challenge for Antimicrobial Therapy","volume":"13","author":"Segundo-Arizmendi","year":"2025","journal-title":"Microorganisms."},{"key":"10.1016\/j.ejpb.2025.114966_b0135","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/ph14090895","article-title":"Manufacturing Bacteriophages (Part 2 of 2): Formulation, Analytics and Quality Control Considerations","volume":"14","author":"Moraes de Souza","year":"2021","journal-title":"Pharmaceuticals."},{"key":"10.1016\/j.ejpb.2025.114966_b0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12223-011-0039-8","article-title":"The influence of external factors on bacteriophages \u2013 review","volume":"56","author":"Jo\u0144czyk","year":"2011","journal-title":"Folia Microbiol."},{"key":"10.1016\/j.ejpb.2025.114966_b0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1208\/s12249-020-01673-5","article-title":"The Stabilizing Excipients in Dry State Therapeutic Phage Formulations","volume":"21","author":"Zhang","year":"2020","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejpb.2025.114966_b0150","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejpb.2019.08.004","article-title":"Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections","volume":"142","author":"Lin","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114966_b0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijpharm.2017.01.060","article-title":"Effects of storage conditions on the stability of spray dried, inhalable bacteriophage powders","volume":"521","author":"Leung","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114966_b0160","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ejpb.2012.12.022","article-title":"Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections","volume":"84","author":"Vandenheuvel","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114966_b0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.21775\/cimb.040.303","article-title":"Bacteriophage Encapsulation Using Spray Drying for Phage Therapy","volume":"40","author":"Malik","year":"2021","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.ejpb.2025.114966_b0170","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1007\/s11095-016-1892-6","article-title":"Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections","volume":"33","author":"Leung","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114966_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120200","article-title":"Phage cocktail powder for Pseudomonas aeruginosa respiratory infections","volume":"596","author":"Li","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114966_b0180","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2672.2010.04863.x","article-title":"In vitro lung delivery of bacteriophages KS4-M and \u03a6KZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis","volume":"110","author":"Golshahi","year":"2011","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ejpb.2025.114966_b0185","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2180-11-102","article-title":"Sequencing and characterization of Pseudomonas aeruginosa phage JG004","volume":"11","author":"Garbe","year":"2011","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.ejpb.2025.114966_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03451","article-title":"A comparison of models for the analysis of the kinetics of drug release from PLGA-based nanoparticles","volume":"6","author":"Pourtalebi Jahromi","year":"2020","journal-title":"Heliyon."},{"key":"10.1016\/j.ejpb.2025.114966_b0195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/1735-5362.228958","article-title":"The effect of different coating materials on the prevention of powder bounce in the next generation impactor","volume":"13","author":"Khalili","year":"2018","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114966_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126014","article-title":"Inhalable spray-dried nano-in-microparticles encapsulating anandamide: a novel approach for the treatment of asthma","volume":"683","author":"H\u00fcbl","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114966_b0205","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202207301","article-title":"A Monoclonal Human Alveolar Epithelial Cell Line (\u201cArlo\u201d) with Pronounced Barrier Function for Studying Drug Permeability and Viral Infections","volume":"10","author":"Carius","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejpb.2025.114966_b0210","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1039\/D2TB02700C","article-title":"Imitating the microenvironment of native biofilms using nanofibrous scaffolds to emulate chronic wound infections","volume":"11","author":"W\u00e4chter","year":"2023","journal-title":"J. Mater. Chem. B."},{"key":"10.1016\/j.ejpb.2025.114966_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121492","article-title":"Formulation of spray dried enzymes for dry powder inhalers: An integrated methodology","volume":"615","author":"Fernandes","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114966_b0220","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2009.10.010","article-title":"Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation","volume":"142","author":"Jensen","year":"2010","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejpb.2025.114966_b0225","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3390\/ph18060923","article-title":"Development of Mannitol-Based Microparticles for Dry Powder Inhalers: Enhancing Pulmonary Delivery of NSAIDs","volume":"18","author":"Party","year":"2025","journal-title":"Pharmaceuticals."},{"key":"10.1016\/j.ejpb.2025.114966_b0230","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10159","article-title":"Inhalable bacteriophage powders: Glass transition temperature and bioactivity stabilization","volume":"5","author":"Chang","year":"2020","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ejpb.2025.114966_b0235","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijpharm.2014.06.026","article-title":"Instability of bacteriophages in spray-dried trehalose powders is caused by crystallization of the matrix","volume":"472","author":"Vandenheuvel","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114966_b0240","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/pr8070788","article-title":"Spray Drying for the Preparation of Nanoparticle-Based Drug Formulations as Dry Powders for Inhalation","volume":"8","author":"Malamatari","year":"2020","journal-title":"Processes."},{"key":"10.1016\/j.ejpb.2025.114966_b0245","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cis.2015.05.003","article-title":"Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers","volume":"223","author":"Sosnik","year":"2015","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2025.114966_b0250","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.drudis.2021.04.009","article-title":"Leucine as an excipient in spray dried powder for inhalation","volume":"26","author":"Alhajj","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2025.114966_b0255","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1517\/17425247.2016.1102224","article-title":"Inhalable nanocomposite microparticles: preparation, characterization and factors affecting formulation","volume":"13","author":"Elsayed","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2025.114966_b0260","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40199-019-00317-9","article-title":"The effect of metal salts on aerosol performance of spray dried carrier-free formulations of levofloxacin","volume":"28","author":"Barazesh","year":"2020","journal-title":"Daru."},{"key":"10.1016\/j.ejpb.2025.114966_b0265","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5339\/gcsp.2015.2","article-title":"Inhaled nano- and microparticles for drug delivery","volume":"2015","author":"El-Sherbiny","year":"2015","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"10.1016\/j.ejpb.2025.114966_b0270","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.3390\/ijms26094320","article-title":"Nano-Spray-Drying of Cyclodextrin\/Ibuprofen Complexes with Aerosolization-Enhancing Additives for Pulmonary Drug Delivery","volume":"26","author":"Motzwickler-N\u00e9meth","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2025.114966_b0275","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1021\/jp0262822","article-title":"An Investigation into the Crystallization of \u03b1,\u03b1-Trehalose from the Amorphous State","volume":"107","author":"McGarvey","year":"2003","journal-title":"J. Phys. Chem. B."},{"key":"10.1016\/j.ejpb.2025.114966_b0280","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/02786826.2016.1177163","article-title":"Effect of crystallization kinetics on the properties of spray dried microparticles","volume":"50","author":"Baldelli","year":"2016","journal-title":"Aerosol Sci. Technol."},{"key":"10.1016\/j.ejpb.2025.114966_b0285","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1016\/j.xphs.2024.06.018","article-title":"Leucine as a Moisture-Protective Excipient in Spray-Dried Protein\/Trehalose Formulation","volume":"113","author":"Zhang","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114966_b0290","doi-asserted-by":"crossref","DOI":"10.1063\/1.3304738","article-title":"Plasticization and antiplasticization of polymer melts diluted by low molar mass species","volume":"132","author":"Stukalin","year":"2010","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejpb.2025.114966_b0295","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/scipharm88040052","article-title":"Development and Characterization of Glimepiride Novel Solid Nanodispersion for Improving its Oral Bioavailability","volume":"88","author":"Qushawy","year":"2020","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ejpb.2025.114966_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.chphi.2023.100254","article-title":"Spectroscopic (FT-IR, FT-Raman, NMR and UV\u2013visible), ADMET and molecular docking investigation of aztreonam as anti-tuberculosis agent","volume":"7","author":"Mani","year":"2023","journal-title":"Chem. Phys. Impact."},{"key":"10.1016\/j.ejpb.2025.114966_b0305","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/jamp.2013.1078","article-title":"Design, Characterization, and Aerosol Dispersion Performance Modeling of Advanced Spray-Dried Microparticulate\/Nanoparticulate Mannitol Powders for Targeted Pulmonary Delivery as Dry Powder Inhalers","volume":"27","author":"Li","year":"2014","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ejpb.2025.114966_b0310","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-60327-164-6_7","article-title":"Enumeration of Bacteriophages by Double Agar Overlay Plaque Assay","volume":"501","author":"Kropinski","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejpb.2025.114966_b0315","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cryobiol.2013.03.007","article-title":"Effect of buffer systems and disaccharides concentration on Podoviridae coliphage stability during freeze drying and storage","volume":"66","author":"Dini","year":"2013","journal-title":"Cryobiology."},{"key":"10.1016\/j.ejpb.2025.114966_b0320","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejpb.2018.02.033","article-title":"Effect of storage temperature on the stability of spray dried bacteriophage powders","volume":"127","author":"Leung","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114966_b0325","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1016\/j.jmb.2015.07.023","article-title":"Influence of Internal DNA Pressure on Stability and Infectivity of Phage \u03bb","volume":"427","author":"Bauer","year":"2015","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejpb.2025.114966_b0330","doi-asserted-by":"crossref","first-page":"34338","DOI":"10.1038\/srep34338","article-title":"Biodiversity of bacteriophages: morphological and biological properties of a large group of phages isolated from urban sewage","volume":"6","author":"Jurczak-Kurek","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2025.114966_b0335","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1248\/cpb.40.3222","article-title":"Stability in Aqueous Solution of Two Monocylic \u03b2-Lactam Antibiotics: Aztreonam and Nocardicin A","volume":"40","author":"M\u00e9ndez","year":"1992","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2025.114966_b0340","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnw002","article-title":"Host receptors for bacteriophage adsorption","volume":"363","author":"Bertozzi Silva","year":"2016","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ejpb.2025.114966_b0345","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114966_b0350","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/pathogens3030680","article-title":"Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs \u2013 A Review","volume":"3","author":"Sousa","year":"2014","journal-title":"Pathogens."},{"key":"10.1016\/j.ejpb.2025.114966_b0355","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1038\/s41598-017-05253-9","article-title":"Modifications of Pseudomonas aeruginosa cell envelope in the cystic fibrosis airway alters interactions with immune cells","volume":"7","author":"Hill","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2025.114966_b0360","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejps.2017.04.003","article-title":"The influence of mannitol on morphology and disintegration of spray-dried nano-embedded microparticles","volume":"104","author":"Torge","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114966_b0365","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.cmi.2022.01.006","article-title":"The effects of different doses of inhaled bacteriophage therapy for Pseudomonas aeruginosa pulmonary infections in mice","volume":"28","author":"Chang","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejpb.2025.114966_b0370","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00441-007-0482-7","article-title":"Effects of hyperosmotic stress on cultured airway epithelial cells","volume":"330","author":"Nilsson","year":"2007","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejpb.2025.114966_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107260","article-title":"PBP-3 directed therapy in VIM-producing Pseudomonas aeruginosa creates bacterial transformers, persisters in disguise","volume":"64","author":"Smith","year":"2024","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.1016\/j.ejpb.2025.114966_b0380","first-page":"1297","article-title":"The Rate of Killing of Escherichia coli by \u03b2-Lactam Antibiotics Is Strictly Proportional to the Rate of Bacterial Growth","volume":"132","author":"Tuomanen","year":"1986","journal-title":"J. Gen. Microbiol."},{"key":"10.1016\/j.ejpb.2025.114966_b0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304491","article-title":"The interplay of Pseudomonas aeruginosa and Staphylococcus aureus in dual-species biofilms impacts development, antibiotic resistance and virulence of biofilms in in vitro wound infection models","volume":"19","author":"Vestweber","year":"2024","journal-title":"PLoS ONE."},{"key":"10.1016\/j.ejpb.2025.114966_b0390","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3389\/fmicb.2017.01229","article-title":"A Genotypic Analysis of Five P. aeruginosa Strains after Biofilm Infection by Phages Targeting Different Cell Surface Receptors","volume":"8","author":"Pires","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejpb.2025.114966_b0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168615","article-title":"Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms","volume":"12","author":"Chaudhry","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.ejpb.2025.114966_b0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011602","article-title":"Phage-antibiotic synergy: Cell filamentation is a key driver of successful phage predation","volume":"19","author":"Bulssico","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejpb.2025.114966_b0405","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03219-23","article-title":"Exploiting phage-antibiotic synergies to disrupt Pseudomonas aeruginosa PAO1 biofilms in the context of orthopedic infections","volume":"12","author":"De Soir","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ejpb.2025.114966_b0410","doi-asserted-by":"crossref","unstructured":"C. Gu Liu, S.I. Green, L. Min, J.R. Clark, K.C. Salazar, A.L. Terwilliger, H.B. Kaplan, B.W. Trautner, R.F. Ramig, A.W. Maresso, 2020. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry. mBio. 11, e01462-20. doi: 10.1128\/mbio.01462-20.","DOI":"10.1128\/mBio.01462-20"},{"key":"10.1016\/j.ejpb.2025.114966_b0415","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2217\/fmb.10.125","article-title":"Pseudomonas aeruginosa biofilms in cystic fibrosis","volume":"5","author":"H\u00f8iby","year":"2010","journal-title":"Future Microbiol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125003443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125003443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:42:20Z","timestamp":1777592540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125003443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":83,"alternative-id":["S0939641125003443"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114966","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of spray-dried phage-aztreonam microparticles for inhalation therapy of Pseudomonas aeruginosa lung infections","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114966"}}